<i>IL-1RN</i>gene polymorphisms reduces thyroid cancer risk in Chinese Han population

Huajing Li,Yue Wu,Ruimin Zhao,Xin Chen,Wanli Ren,Honghui Li,Peng Han,Yuan Shao,Jiansheng Wang
DOI: https://doi.org/10.1002/mc.23244
2020-01-01
Molecular Carcinogenesis
Abstract:The purpose of this study was to investigate the effect ofIL-1RNpolymorphisms on thyroid cancer (TC) risk in Han population. Genotypes of four single nucleotide polymorphisms (SNPs) (rs17042888, rs928940, rs3181052, and rs452204) were analyzed by Agena MassARRAY. Meanwhile, we used the logistic regression to calculate the odds ratios (ORs) and 95% confidence intervals (CIs), and significant differences were evaluated byttest and chi(2)test. Findings found that allele "G" of rs452204 and rs3181052 in interleukin-1 receptor antagonist (IL-1RN) reduced the risk of TC. (OR = 0.72, 95% CI = 0.55-0.94,p = .017; OR = 0.73, 95% CI = 0.56-0.94,p = .017, respectively). Hierarchical analysis indicated that three SNPs (rs17042888, rs3181052, and rs452204) significantly reduced the risk of TC among females or individuals older than 48 years (p < .05). Our findings indicate thatIL-1RNpolymorphisms may contribute to a protective role against TC risk.
What problem does this paper attempt to address?